Clinical trials

Recherche d’études cliniques

Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.

Réinitialiser

Études cliniques 3370

Étude / NCT ⇅ Molécule ⇅ Maladie ⇅ Phase ⇅ Statut ⇅ Résultat ⇅ Sponsor ⇅ Pays / centres ⇅ Période ⇅ Détail
NCT04738487
Coformulation of Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembroliz…
pembrolizumab/vibostolimab Parkinson Phase 3 TERMINATED En attente / non publié Merck Sharp & Dohme LLC United States, Brazil, Canada, Chile, China, Dominica… 2021-04-07 → 2026-01-27 Ouvrir
NCT04634877
Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemother…
Pembrolizumab Parkinson Phase 3 ACTIVE_NOT_RECRUITING En attente / non publié Merck Sharp & Dohme LLC United States, Argentina, Austria, Belgium, Canada, C… 2021-01-10 → 2026-11-20 Ouvrir
NCT07592767
RESvEraTrol in Parkinson's Disease (RESET)
Trans-Resveratrol Parkinson Phase 2 RECRUITING En attente / non publié Georgetown University United States · Georgetown University Hospital, Washi… 2026-09-17 → 2029-06-01 Ouvrir
NCT07827456
MRI-Guided Temporal Interference Stimulation for Parkinson's Disease
Temporal Interference Stimulation… Parkinson Non applicable NOT_YET_RECRUITING En attente / non publié Tongji Hospital Non communiqué 2026-09-15 → 2027-06-10 Ouvrir
NCT07056361
Stimulating Specific Brain Areas (VOP/VIM) With Electricity to Improve …
Direct cortical stimulation and d… Parkinson Non applicable RECRUITING En attente / non publié Jorge Gonzalez-Martinez United States · University of Pittsburgh, Pittsburgh,… 2022-12-16 → 2030-12-31 Ouvrir
NCT01019343
Physiological Investigations of Movement Disorders
Transcranial Direct Current Stimu… Parkinson Non applicable COMPLETED En attente / non publié National Institute of Neurologica… United States · National Institutes of Health Clinica… 2009-12-08 → 2020-10-09 Ouvrir
NCT07738107
ATR 1072 in Participants With PRKAG2 Syndrome
ATR 1072 Parkinson Phase 1/2 RECRUITING En attente / non publié Atrium Therapeutics United States · St Luke's Mid American Heart Institut… 2026-09-14 → 2028-10 Ouvrir
NCT04127578
Phase 1/2a Clinical Trial of PR001 (LY3884961) in Patients With Parkins…
LY3884961 Parkinson Phase 1/2 ACTIVE_NOT_RECRUITING En attente / non publié Prevail Therapeutics United States, Israel · Esperanza Clinical, 25220 Han… 2020-01-03 → 2031-08-31 Ouvrir
NCT05350150
VNS-EPS — Non-invasive Vagus Nerve Stimulation in Patients Undergoing E…
Auricular Vagal Nerve Stimulation SEP Non applicable ACTIVE_NOT_RECRUITING En attente / non publié Northwell Health United States · Kristie Coleman, New York, United Sta… 2022-08-22 → 2026-07-30 Ouvrir
NCT01479075
Centrin — The Effect of Central Insulin on Insulin Sensitivity and Ener…
intransal insulin SEP Phase 4 COMPLETED En attente / non publié German Diabetes Center Germany · German Diabetic Center, Düsseldorf, Germany 2011-08 → 2014-06 Ouvrir
NCT07577102
taVNS-FMS — Unilateral and Bilateral taVNS in Fibromyalgia
taVNS SEP Non applicable COMPLETED En attente / non publié German Diabetes Center Turkey (Türkiye) · Darülaceze Medical Center, Istanbu… 2022-01-01 → 2023-06-20 Ouvrir
NCT01846741
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients E…
M106 VNS Therapy System SEP Non applicable COMPLETED En attente / non publié Cyberonics, Inc. United States · Albany — centre non communiqué, Alban… 2013-07 → 2015-08 Ouvrir
NCT07782866
MindVybe tVNS/APS for Wellbeing in Breast Cancer Survivors
Transcutaneous vagus nerve and ac… SEP Non applicable COMPLETED En attente / non publié The Healing Consciousness Foundat… United States · Redeemer Health, Meadowbrook, United … 2025-04-14 → 2026-07-24 Ouvrir
NCT07730762
A Study of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) for…
transcutaneous auricular vagus ne… SEP Non applicable ACTIVE_NOT_RECRUITING En attente / non publié Xijing Hospital China · Xijing Hospital, Shanxi, China 2024-08-30 → 2026-12-31 Ouvrir
NCT06935474
C-CAR168 CAR T Cell Therapy for Refractory Autoimmune Disease
C-CAR168 SEP Phase 1/2 WITHDRAWN En attente / non publié RenJi Hospital United States · AbelZeta, Inc., Rockville, United Sta… 2026-07 → 2030-06 Ouvrir
NCT07729826
C-CAR168 CAR T-Cell Therapy for the Treatment of Lupus Nephritis Refrac…
C-CAR168 SEP Phase 2 NOT_YET_RECRUITING En attente / non publié RenJi Hospital Non communiqué 2026-09-30 → 2029-09-01 Ouvrir
NCT02493049
Pilot Trial of Domperidone in Relapsing-Remitting Multiple Sclerosis (R…
Domperidone SEP Phase 2 COMPLETED En attente / non publié University of Calgary Canada · Calgary MS Clinic at Foothills Medical Centr… 2015-08 → 2019-02 Ouvrir
NCT07189325
DESIRE MS — A Prospective Randomized Non-inferiority Trial Comparing An…
Platform therapies (Dimethyl Fuma… SEP Phase 3 RECRUITING En attente / non publié University Hospital, Montpellier France · Neurology Department, Hospital Gui de Chauli… 2026-06-15 → 2031-06 Ouvrir
NCT03477500
Randomized Autologous heMatopoietic Stem Cell Transplantation Versus Al…
Cyclophosphamide and ATG SEP Phase 3 ACTIVE_NOT_RECRUITING En attente / non publié Haukeland University Hospital Denmark, Netherlands, Norway, Sweden · Akademiska sju… 2018-03-21 → 2028-03-21 Ouvrir
NCT05805839
A Study of Imaging in Demyelinating Diseases
C-11 ER176 Radiotracer SEP Phase 2 ENROLLING_BY_INVITATION En attente / non publié Mayo Clinic United States · Mayo Clinic Minnesota, Rochester, Uni… 2023-07-10 → 2028-05 Ouvrir
NCT02784210
Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple…
Methylprednisolone SEP Phase 2 RECRUITING En attente / non publié Hoffmann-La Roche United States · National Institutes of Health Clinica… 2016-10-05 → 2028-12-31 Ouvrir
NCT07826689
A Phase 1/2a Study of Oral PRO-1562 in Healthy Subjects and Patients Wi…
PRO-1562 Oral Capsules SEP Phase 1/2 NOT_YET_RECRUITING En attente / non publié Progentos Therapeutics Australia · Cmax Clinical Research, Adelaide, Austral… 2026-10 → 2029-02 Ouvrir
NCT07825389
A Study of C-CAR168 in Participants With Progressive Multiple Sclerosis
C-CAR168 SEP Phase 1/2 NOT_YET_RECRUITING En attente / non publié RenJi Hospital Non communiqué 2027-02 → 2030-02 Ouvrir
NCT07827586
SONATA-MS — Non-interventional Study of Subcutaneous Ocrelizumab in Per…
Ocrelizumab SEP À vérifier NOT_YET_RECRUITING En attente / non publié Hoffmann-La Roche Non communiqué 2026-09-30 → 2029-05-31 Ouvrir
NCT07827716
A Study to Evaluate the Preliminary Efficacy and Safety of Terfenadine …
Terfenadine SEP Phase 2 RECRUITING En attente / non publié Chuan Qin China · Tongji Hospital, Tongji Medical College, Huaz… 2026-08-15 → 2028-10-30 Ouvrir